Trump administration fast-tracks ibogaine research for PTSD

Summary
The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other serious mental illnesses. Health and Human Services Secretary Robert F. Kennedy Jr. announced a more than $25 million investment from his department, along with the Department of Veterans Affairs, to speed
Description from Washington Examiner.
Who is covering this
-
Trump administration fast-tracks ibogaine research for PTSD
The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other serious mental illnesses. Health and Human Services Secretary Robert F. Kennedy Jr....
Elevated risk






Comments
Comments need JavaScript.